In this week’s View, Dr. Eagle looks at predicting long-term outcomes in patients with recurrent pericarditis. He then ...
Together, we rise to the challenges of today. We share knowledge and identify real solutions for tomorrow. And with dedicated clinicians and partners like you, we are advancing heart care worldwide, ...
We want to hear from you. Tell us what you think here or leave a comment on the app's iTunes or Google Play page. The updated ASCVD Risk Estimator Plus uses up-to-date ACC clinical policy and user ...
Explore the different ways the ACC is helping to improve clinician well-being, whether it's providing clinician education, encouraging conversations that matter, reducing unnecessary administrative ...
A unique blend of forum and network, the Cardiovascular (CV) Team Member Section and Leadership Council is advancing ACC's efforts to identify and address gaps in areas of professional importance to ...
There is a significant and independent prognostic value of ESC criteria for suspected myocarditis and the updated Lake-Louise criteria (LLC), respectively. ESC criteria were positive in a larger ...
Tell us about you so we can serve you better. ACC requests information from its members on gender, ethnicity and race as part of the College's aim to develop a more diverse and inclusive ...
Welcome to the Cardiovascular (CV) Dyad Leadership Strategic Planning Series! In episode one of four, Dr. Jeff Carstens discusses with Drs. Tom Draper and Michael Montgomery steps to developing a ...
The ACC Statin Intolerance App guides clinicians through the process of managing and treating patients who report muscle symptoms while on statin therapy. Clinicians can use the app to: Answer ...
Cardiovascular disease is the number one cause of death and the leading driver of health care costs in the U.S. We own the problem. We must own the solution.
Our records indicate that the Ovid subscription has been in our system for over a year. Please contact your administrator or librarian to make sure the institutional subscription to Cardiosource Plus ...